MDR1 and multidrug resistance-associated protein (MRP) gene expression in epithelial ovarian tumors
- 19 April 1996
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 102 (1-2) , 7-16
- https://doi.org/10.1016/0304-3835(96)04143-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Mechanisms of drug resistance in ovarian cancerCancer, 2010
- Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 1995
- Expression of multidrug resistance-associated protein (MRP) in thyroid cancersCancer Letters, 1995
- The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug ResistanceBiochemical and Biophysical Research Communications, 1995
- High mdrl- and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukaemiasCancer Letters, 1994
- Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.Journal of Clinical Oncology, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Prognostic Factors in Ovarian CancerHematology/Oncology Clinics of North America, 1992
- Two homologous mixed Müllerian tumor lines of the ovary and their characteristicsCancer, 1990
- Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemiaCancer, 1965